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B cell non-Hodgkin's lymphomas (NHL)' represent malignant counterparts of
thevarious stages ofthe physiological B cell development. Manyimmunophenotyp-
ical and functional properties are retained in the malignant situation. Thus, follicle
center cell (FCC)-derived lymphomas have an immunophenotype ofmature B cells
with, among other antigens, weak or absent expression ofCD10 and strong expres-
sion ofCD19, CD20, CD22, HLA-DR, and surface Igs. In 10-30% of the cases,
however, the cells fail to express detectable Ig proteins on the membrane or in the
cytoplasm (1, 2). It is not known why Ig are not expressed in these mature B cells.
Besides at the gene level, a block in the Ig synthesis could be located at any step
between gene and product: Ig gene transcription, processing ofthe primary tran-
script, translation of mature mRNA, or assembly ofthe final protein product. At
the gene level, Ig synthesis requires a functional Ig gene rearrangement on one of
the alleles. Nonfunctional rearrangements canbeproduced byassociationwith pseudo
genes, ofwhich three are interspersed between theJHgenes, and out-of-phase rear-
rangement of VHandJHgenes. Gene transcription may also be disturbed by stop
codons, nonsense codons, or mutations in promoter regions or splice sites created
by the recombinational processes.
A reciprocal translocation t(14;18)(g32;g21) is found in -85% of follicular lym-
phomas. In this translocation, the bcl-2 gene on chromosome 18 is joined to one
oftheJH genes by similar mechanisms as involved in normal VDJH joining (3).
Theresulting bcl-2/Ig hybrid cannot serveas afunctional Iggene. Alsot(11;14xg13;q32)
and t(8;14)(g24;g32) may cause disruption and nonfunctionality of the involved Ig
H chain gene (3, 4). In the present study, we investigated whether translocations,
deletions, oraberrant rearrangements involving theIgHchain genes might explain
defective Ig H chain production in FCC-derived lymphomas and leukemias.
This work wassupportedby grant6.2.1. from theJ. A. CohenInstitute, IRS, Leiden, TheNetherlands.
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lymphoma; PCR, polymerise chainreaction; TdT, terminal transferase;TRITC, tetramethyl-rhodamin
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Patients
Materials and Methods
49 patients with FCC-derived NHL collected in the Laboratory of Pathology, University
of Leiden, between 1981 and 1988 were studied . Histological diagnoses were made according
to the Kiel classification (5) . In eight cases, multiple successive samples were available . 53
lymph node biopsies and one pleural effusion aspirate from a patient with a histologically
documented history of follicular lymphoma (case 44 ; Table II) were studied . Blood cells of
two patients with an unusual form of B cell acute lymphocytic leukemia (ALL) were ana-
lysed . In total, 19 cases of FCC-derived tumors lacked expression of Ig H chains (Table I) .
Immunophenotypic Analysis
For detection of Ig expression, two methods were applied in all cases studied :
Indirect Immunoperoxidase Tests .
￿
Cryostat sections were incubated with rabbit polyclonal
F(ab)z anti-Ig L chain and IgM, IgD, IgG, and IgA H chain antisera (Dakopatts, Copen-
hagen, Denmark) and with a horseradish peroxidase (HRP)-conjugated swine anti-rabbit
antiserum (Dakopatts) as a second layer. Staining was performed with 3-amino-9-ethylcarbazol
(Aldrich Chemical Co., Beerse, Belgium). Two cases were studied with mouse mAbs raised
against IgGI, -2, -3, -4, and IgAl and -2 subclasses (Central Laboratory of Blood Transfu-
sion, CLB, Amsterdam ; Dr. J . Haaymans, TNO, Rijswijk, The Netherlands) in an indirect
immunoperoxidase test . The second step consisted of a rabbit anti-mouse HRP-conjugated
antiserum (Dakopatts) .
Direct Two-colorImmuno,fluorescence Tests.
￿
Cryostat sections were incubated with burro, goat,
or rabbit polyclonal FITC-conjugated anti-Ig antibodies against rc, IgM, IgD, IgG, and IgA,
in combination with a tetramethyl-rhodamin isothyocyanate (TRITC)-conjugated antiserum
against A L chains . A separate section was incubated with an FITC-conjugated anti-X an-
tiserum. Antisera were obtained from Kallestad Laboratories, Inc . (Austin, TX), Nordic (Til-
burg, The Netherlands), and Dakopatts .
For detection of B cell- and T cell-associated antigens in frozen tissue sections, a two-
or three-step indirect immunoperoxidase assay was used, the latter consisting of subsequent
incubation with HRP-conjugated rabbit anti-mouse and HRP-conjugated swine anti-rabbit
antisera (Dakopatts) . The following primary antibodies were used : CD2 (CLBTII ; CLB),
CD3 (Leu-4), CD4 (Leu-3), CD5 (Leu-1), CD8 (Leu-2) (all obtained from Becton Dickinson
& Co ., Sunnyvale, CA), CD10 (J5), CD19 (B4), CD20 (BI) (all obtained from Coulter Elec-
tronics, Inc., Hialeah, FL), CD22 (Leu-14), and anti-HLA-Dr (Becton Dickinson & Co.) .
The lymphoid origin of all diffuse large cell lymphomas tested was confirmed by the staining
for CD45 (Dako-LC ; Dakopatts) .
Both cases ofALL were immunophenotyped in suspension and on cytocentrifuge prepara-
tions (6) . Primary antibodies used were : goat or burroFITC and TRITC-conjugated anti-Ig
antisera (Kallestad, Nordic), for detection of cell surface Ig and cytoplasmic Fr chains, rabbit
anti-terminal transferase (TdT) (Bethesda Research Laboratories, Gaithersburg, MD), CD10
(BA3) (Hybritech, Luik, Belgium), CD19 (B4), and CD20 (Bl), CD24 (BAI) (Hybritech),
CD2 (Leu-5) (Becton Dickinson&Co.), andCD7 (WT1) (Sanbio, Uden, The Netherlands) .
Immunogenotypic Analysis
High molecular weightDNA was isolated according to standard methods. The DNAs were
digested to completion with various restriction enzymes, size fractionated in 0.7% agarose
gels, and transferred to Genescreen plus' or Biotrace filters . Blots were hybridized with
random primer 32P-labeled probes, washed in 0.3 x SSC/0.1%a SDS at 65°C, and autoradio-
graphed at - 70°C . The filters were reused up to five times with different probes after removal
of the previous signal by "stripping" in 0 .1 x SSC/0.1% SDS at 100°C (controlled by over-
night exposure) .
The H chain rearrangements were detected with a 2 .4-kb Sau IIIa IgJH probe in Eco
RI-, Hind III-, and Bam HI-digested DNA in all cases (7) . In case the number of rear-
ranged H chain alleles could not definitively be determined, additional hybridizations were
done with Pst I-, Bgl II-, Sac I-, and Xba I-digested tumor DNA . The same filters wereDE
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hybridized
with a 2
.8-kb
Eco RI-Hind III fragment of the bcl-2 gene containing the major
breakpoint
area and a 3' flanking 1
.5-kb
Hind III-Eco RI fragment to study the translocation
t(14;18)(g32;q21).
Rearrangements of Ig K genes were studied with a 2
.5-kb
Eco RI ck probe
in
Bam HI- and Hing III-digested DNA and X gene rearrangements with a 3
.5-kb
Eco RI-
Hind
III cX-2 probe, using Eco RI-digested DNA
.
The c-myc gene was studied with a 1
.4-kb
Eco
RI-Cla I fragment containing the third exon of c-myc
.
Cytogenetic
Analysis
Cytogenetic
analyses were performed on three peripheral blood samples, three lymph node
biopsies,
and one pleural fluid aspirate
.
The cellswere cultured for 3, 5, and 7 d in the pres-
ence
of PHA (Wellcome, Dartford, UK), Escherichia coli 055
:B5
LPS B (Difco Laboratories,
Inc.,
Detroit, MI) or phorbol 12-myristate 13-acetate (Sigma Chemical Co
.,
St
.
Louis, MO)
.
Polymerase
Chain Reaction (PCR)
DNA
sequences of the translocation junction of t(14
;18)
were amplified, using a modified
method
as described by Lee et al
.
(8)
.
Two synthetic oligonucleotides were synthesized as
primer
for PCR
.
One primer was complementary to the plus strand of the major breakpoint
region
of the bcl-2gene (5'-TTT GAC CTT TAG AGA GTT GC-3), the other complemen-
tary
to the minus strand of the homologous region 3' of eachfH gene (5'-ACC TGA GGA
GAC
GGT GAC C-3')
.
Samples (0
.5-1
Fig) of tumor DNA were denatured for 5 min at 100°C
in
a buffer containing 50 mM KCI, 10 mM Tris-HCI (pH 8
.3),
2
.5
MM MgCl2, 0
.2
mg/ml
acetylated
BSA, 2001tM deoxynucleotide triphosphate (each offour), and 1 pM ofeach primer
.
1
U ofheat-stable Taq-DNA-polymerase was added (Perkin-Elmer Corp
.,
Norwalk, CT) (9)
.
32
cycles of denaturing (1 min
;
100°C) and reannealing/extension (six cycles for 2 min, six
cycles
for 3 min, six cycles for 3
.5
min, six cycles for 4 min, eight cycles for 5 min
;
65°C)
were
performed, using an automated robot system (ROB 3
;
P & P Elektronic, K61n, FRG)
.
Filters
were made by spotting 1 til of 100 gl of the samples on Genescreen Plus filters and
by
Southern blotting after size separating of 5 p
.l
of 100 Al of the samples on 1
.7%
agarose
gels.
The filters were hybridized to JH and bcl-2 probes as described above
.
Results
Immunophenotypic
Analysis
.
￿
16
cases of FCC-derived tumors lacked IgH expres-
sion.
12 of these also lacked L chain expression
.
All lymphomas showed reactivity
with
at least two of the B cell-specific reagents, CD19, CD20, or CD22, but no reac-
tivity
with two panels of T cell-specific or -associated antibodies (CD2 and CD3
or
CD4, CD5, and CD8)
.
One patient presented with a composite B cell lymphoma
of
Ig- follicular lymphoma and Ig- lymphoblastic lymphoma
.
Both components
were
studied separately after FAGS and have been described elsewhere (10) (enumerated
as
cases 6 and 17
;
Table I)
.
Two cases of Ig- B-ALL were also studied
.
Case 18
presented
with a relapse ALL-L3 according to the French-American-British (FAB)
leukemia
classification
.
Although the tumor cells were positive for B cell markers
and
CD10, they did not express Ig or TdT Patient 19 had an Ig-, TdT- ALL (FAB-
L2)
with expression of B cell markers and CD10
.
30
Ig H chain-positive FCC-derived NHL were studied as controls (Table II)
.
The
B cell origin of the tumor cells was demonstrated by the monotypic Ig expres-
sion
in combination with reactivity with at least one of the B cell-specific reagents
.
DNA
and Karyotype Analysis
.
￿
All
cases studied showed rearrangement of one or
both
Ig H chain alleles (Tables I and II)
.
The Ig L chain genes were also rearranged
in
40 cases analyzed
.
Since in t(14
;18)
the bcl-2 gene on the long arm of chromosome
18
adjoins theJH genes, this translocation could be determined by detection ofrear-
ranged
fragments of similar size by both the JH and the bcl-2 probes on basis of61 6
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TABLE I
Irnmunogenotype and translocations in IgH-
FCC-derived Lymphomas and B-ALL
a/b, samples of two successive biopsies were available; R, rearrangement; - ,
negative; + , positive.
" Tumors 6 and 17 were found in the same patient. Case 6 represents a follicu-
lar lymphoma, in which a lymphoblastic leukemia developed (case 17).
1 Karyotype analysis: 47Y, -X, lq', lq-, 1p-, 3p-, 6q-, 7q', +12q', 13q-,
14q', 15q-, + 16, - 20, 22q'.
3 Karyotype analysis: 46XX, +1, -6, 14q'.
II Karyotype analysis: 46X, -Y, -9, del(12)(p12), - 13, - 13, - 14, t(14;18),
+ markers.
comigration. In 14 of 19 (74%) follicular centroblastic/centrocytic lymphomas
(FCB/CC), four ofseven (57%) diffuse CB/CC, 11 of 20 (55%) diffuse CB, and in
all three lymphoblastic lymphoma/leukemia, t(14;18) was found (Tables I and II;
Fig. 1 A-C). The majority ofthe breakpoints in the bel-2 gene are clustered within
the major breakpoint region, which is located in a 4.3 Hind III fragment (11). In-
volvement of this region was demonstrated by Southern blotting in 18 of 32 cases
with bcl-2 rearrangement (56%) and confirmed by amplification ofthe breakpoint
region with the PCR in 16 cases (Fig. 2). The other bcl-2 rearrangements occurred
outside the majorbreakpoint region. No significantdifferences in incidence oftrans-
locations and location ofthe breakpoints were found between the IgH+ and IgH-
follicular lymphomas. In contrast, diffuse IgH- lymphomas had more transloca-
tions than the diffuse IgH+ lymphomas (6 of 8 and 9 of 19, respectively). The
numbers ineach groupare toosmall, however, to attribute significanceto thisfinding
at present (X2 test, 0.05 < p < 0.1).
In 8 of 19 Ig- cases, only one Ig H chain allele was found to be rearranged on
hybridization withJHafterdigestion with at least three restrictionenzymes. Inseven
ofthese eight cases this allele was shown to be involved in t(14;18) by comigration
Diagnosis Cases H chain K L chain
Rearrangements
L chain bcl-2 Other
FCC/CB 1 2R 1R G - 14q'1
2 1R 2R 1R +
3a/b 2R 1R 1R + R c-myc
4 1R 1R G +
5 1R 1R G +
6' 2R 1R 1R +
7a/b 2R 1R G +
8 1R 1R lR -
DCB 9 2R G 1R +
10 1R 2R G +
11 2R 2R G -
12 1R G 1R +
13 2R 1R G + R c-myc
DCB/CC 14 2R 1R G +
15 2R 1R G -
16 1R 1R ND + t(14;18)5
LBL 17' 2R 1R 2R + t(8; 14);R c-myc
18 2R ND ND + t(8;14);R c-myc
19 1R ND ND + -1411DE JONG ET AL.
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Other
R c-myc
a/b, samples of two successive biopsies were available; R, rearrangement; - , negative; + ,
positive.
" Two different translocations t(14;18) were present.
i Karyotype analysis as done: 49-53, XY, 2p - , 6q - , 8q + , 13q + , 17p + , + 21, + markers.
with bcl-2. In the remaining 11 Ig- cases, both H chain alleles were rearranged.
In 8 of these 11 cases, a t(14;18) was present involving one ofthe alleles. In four of
these eight cases, additional rearrangement ofc-myc was found on the DNA level.
Cytogenetical analysis of two cases showed both the t(8;14), in which c-myc is in-
volved, and t(14;18) together in single cells, indicating that both Ig H chain alleles
were not functional.
Using the presence ofrestriction sites for the enzymes Est E2, Pvu II, Rsa I, and
Eco RVbetweentheJH genesin the germline situation, restriction maps ofthe rear-
ranged IgH alleles could beconstructed, thus indicatingwhich oftheJH genes was
involved intherearrangement. The restriction map ofcase 7 strongly suggests rear-
rangement to the pseudoJH3 gene (Fig. 3).
Immunogenotype
TABLE H
and Translocations in IgH+
Cell-derived Lymphomas
Follicle Center
Rearrangements
Diagnosis Cases H chain K L chain X L chain bcl-2
FCC/CB 20 M,k 2R 1R G +
21 G,k 1R IR G -
22 M,k 1R 1R G -
23 M,1 2R G 1R -
24 M,k 2R 2R G +
25 M,D,k 2R 1R G +
26a/b M,l 2R 1R IR +
27a/b M,k 2R IR G +
28a/b A,l 2R G 1R +
29a/b A(G),l IR 1R G +
30 G1,A2,1 4R 2R 3R + +'
DCB 31 M,l 2R 2R 1R -
32 M,D,k 211 IR G +
33 M,l 2R 1R 1R +
34 A,k 2R ND ND +
35 M,k 1R ND ND -
36 G,I 2R G 1R +
37 M,D,k 2R ND ND +
38 M,D,l 1R ND ND -
39 M,l 1R ND ND -
40 A,- 2R G 2R -
41 M,- IR 1R ND -
42 D,- 2R G 1 R +
43 M,- IR G 1R -
44 G,l 2R ND ND +
45 G,- 1R IR G -
DCB/CC 46 G,1 2R 2R IR -
47 G,1 2R G 2R -
48a/b M,1 2R IR 1R +
49 D,- 1R ND ND +61 8
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FIGURE 1 .
￿
Southern blot analysis of Ig H chain and bcl-2 gene organization. DNA from Ig -
lymphomas (A), an Ig- lymphoblastic leukemia (B), and Ig' lymphomas (C) was digested with
the restriction enzymes indicated . Each filter was hybridized with theJH probes (lanes a) and
the bcl-2 probes (lanes b) . Case 18 was also hybridized with a c-myc probe (lanes c) . Lanem shows
the corresponding size marker. Sizes are given in kb pairs . Arrowheads indicate the germline
configuration of the genes, as are also present in the contaminating normal cells in each biopsy
sample . Dashes indicate the rearranged fragments. Comigrating fragments are indicated by double
dashes between the lanes and are seen in all samples exept case 29 . In case 18, the c-myc gene
is rearranged by t(8;14). No comigration of c-myc andJH is seen . The translocation has most
probably taken place in an Ig switch region as in sporadic (non-African) Burkitt'slymphoma (20) .FIGURE 1 . Continued .
DE JONG ET AL.
￿
619
As controls, 30 IgH+ FCC-derived NHL were examined (Table II). Two rear-
rangedH chain alleles were found in 19 cases, of which 14 had t(14;18) on one IgH
allele and functional rearrangement of the other allele . One rearrangedH chain al-
lele without rearrangement of bcl-2 was demonstrated in eight cases . In two addi-
tional cases (29 and 49), however, a single rearranged H chain allele was found in
FIGURE 2 .
￿
Analysis ofthe ma-
jor breakpoint region ofthe bcl-2
gene by amplification by the
PCR . (A) Dot-blot analysiswith
hybridization with the JH
probe . Cases 26, 4, 6, and 27
have t(14 ;18) and translocate in
the major breakpoint area. Case
7 has t(14;18)withtranslocation
outside the major breakpoint
area and is thus negative in the
PCR. Human placental DNA
was used as control . (B) South-
ern blot analysis ofcases 26, 6,
and 4 with hybridization with
the bcl-2 probe, which contains
the major breakpoint region .
Apart from the expected ampli-
fied bcl-2/JH hybrid fragment,
several larger fragments are present in cases 7 and6 (a) . These are caused by the presence ofJH genes
3' ofthe bcl-2/JH join . Since each ofthese genes contains the sequence that is recognized by the primer
for theJH genes, these segments are also amplified . Digestion of the amplified DNA with BstE2, which
cuts 5' of eachJH gene (except JH2), digests away these "tails" of the bcl-2/JH junction, resulting in
the abolishment of extra fragments on hybridization with the bel-2 probe (b) . Sizes are given in bp .620
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FIGURE 3,
￿
Restriction map of case 7. T(14 ;18) has taken place onJH4 (alleleA) . The other Ig
FIGURE 4 .
￿
Analysis of a biclonal lymphoma (case
30) . ForSouthern blot analysis, filters were hybrid-
ized with theJH probe (lanes a) and the bcl-2 probe
(lane b). Arrowheads indicate the germline configu-
ration of the genes; dashes indicate the rearranged
bands. Double dashes between the lanes indicate
comigrating bands, of which two are found . In
amplification withPCR : upon hybridization with the
bcl-2-probe, two fragments of 230 and 200 by are
seen (arrow) (lane c).DE JONG ET AL.
￿
621
combination with rearrangement of bcl-2 in the major breakpoint region. In case
29, this finding was confirmed with eight endonucleases. In both cases, no comigra-
tion of bcl-2 andJH was present, however, and the translocation breakpoint could
not be amplified with PCR(Fig. 1 C), indicating either avariant translocation break-
point on chromosome 14 or association of bcl-2 with an unrelated chromosomal re-
gion . In one case (43) rearrangement of c-myc was found. No association with JH
was present.
Case 30 is of special interest. Immunophenotypical analysis with Ig subclass-specific
antibodies showed uniformexpression ofIgG1 and A and patchy positivity for IgA2.
Hybridization with JH using four restriction enzymes indicated four rearranged
bands. Also, two rearranged is L chain alleles and three rearranged X L chain alleles
were found. These findings suggest a biclonal origin of this tumor. Two different
rearrangements of bcl-2 were found and comigrated each with a differentJH frag-
ment. Moreover, by amplifying thebcl-2/JH breakpoint with PCR, thetwo different
breakpoints could be demonstrated (Fig. 4).
Discussion
Although FCC-derived lymphomas correspond to mature stages in thephysiolog-
ical B cell development and should thus express Igs on theircell membranes, a con-
siderable percentage lack Ig expression (1, 2). Why these tumorcells do not produce
Igs is not clear. Apart from deficiencies at the RNA or protein level or in regulatory
events, the unavailability of a functional Ig H chain gene may be a cause for the
lack of Ig production in these tumors.
We have studied causes of defective Ig H chain synthesis on the gene level in 17
IgH- FCC-derived lymphomas and two cases of ALL. The latter were strongly sug-
gested to be FCC related by the exceptional presence of t(14;18) and their unusual
phenotype. In seven cases, a t(14 ;18) that disturbs the Ig H chain gene was present
while the other Ig allele was either deleted or in germline. The absence of a func-
tional IgH allele therefore indeed excludes Ig H chain production in these cases.
In four othercases the t(14;18) was accompanied by rearrangementof the c-myc gene
on chromosome 8. Karyotype analysis in two of four cases identified an underlying
t(8;14). Involvement of both Ig H chain genes in these translocations identifies this
as the cause of lacking Ig production. In the two other cases a similar mechanism
maybe involved, although cytogenetic proofoft(8;14) couldnot be given, since only
frozen material was available. Analysis ofthe separatedcomponents ofthe composite
lymphoma (samples 6 and 17) revealed that consecutive oncogene activation and
clonal evolution led to the development of the lymphoblastic lymphoma out of a
precursor cell of the follicular tumorconstituent (9). Thelymphoblastic component
had both translocations, while the follicular component, which was also Ig-, only
had the t(14;18). Since only one Ig H chain allele was involved in t(14;18), another
mechanism must account for defective IgH production in this tumor constituent.
Translocation and activation of c-mychave been associated with leukemic progres-
sion in FCC-derived lymphoma (12). Two cases with t(8;14) and t(14;18) indeed
presented as lymphoblasticleukemia. Two caseswith combined c-mycand bcl-2rear-
rangements and one with c-mycrearrangement only, however, were nonleukemic diffuse
centroblastic lymphomas. These different clinical and morphological forms indicate
that translocation and activation ofc-mycmay be involved in progressionof follicular
lymphoma, though not necessarily to leukemic forms.622
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In 8 of 19 Ig- cases, at least one rearranged IgH allele was present and shown
not to be involved in atranslocation(14;18) tothemajorand minorbreakpoint regions
in the 3' region ofthe bcl-2 gene. We did not study the 5' region ofbcl-2, where very
few breakpoints are reported (13). In a recent study, antibodies were raised against
the bcl-2 protein products. Expression ofbcl-2 could be shown in almost all follic-
ularlymphomasstudied, including4of26 lymphomas inwhich no bcl-2 DNA rear-
rangement could be demonstrated (14). The authors suggest that these tumors had
a t(14;18) with breakpoints on chromosome 18 outside the regions detected by their
probes. In view ofthese results, therefore, we cannot exclude that yet more IgH-
tumors had t(14;18) as the cause of defective Ig synthesis.
As discussed above, several other mechanisms directly related to the recombina-
tional process may create nonfunctional IgH genes. Theinvolvement ofthepseudo-
JH3 gene in case 7 may be an example ofinactivation ofone IgH allele by t(14;18)
and the other by nonfunctional rearrangement leading to defective Ig production.
Indications for defects in transcription were given by Siminovitch et al. (15), who
described several diffuse B cell lymphoma cell lines without Ig Hchain expression,
in which one or both H chain alleles were rearranged. Truncated Ig H and L chain
mRNAs were seen on Northern blots in one case, suggesting transcriptional defects
(15). The contribution ofotherpossible mechanisms in defective Igproduction may
be revealed by cloning and sequencing ofIgH alleles in Ig- tumors and needs fur-
ther research.
In 28 of30 IgH+ lymphomas, at least one rearranged IgH allele was present and
not involved in a translocation, accounting for Ig production. Although cases 29
and 49 showed a concomitant bcl-2 rearrangementwith a breakpoint in the major
breakpoint region, in none ofthe cases was comigration ofJH and bcl-2 seen. PCR
confirmed that,JHand bcl-2were not associated. This suggests a variant translocation
of bcl-2, leaving the Ig H chain gene intact and available for Ig synthesis. Possible
mechanisms for this are translocations to a VH region upstream from the function-
ally rearranged VDJ segment, or a bcl-2 translocation to another gene, which has
asimilarinfluence on bcl-2 expression during B cell maturation. This finding agrees
with the findings of Doucette and Chaganti (16), who described translocations of
bcl-2 to VH and switch regions. In case 43 with u chainproduction, similarly, rear-
rangement ofc-myc was accompanied by only one H chain rearrangement. In this
case, a variant translocation of the c-myc gene to chromosome 2 or 22, as can be
found in Burkitt's lymphoma, may be present (17).
Wehave not studied the mechanisms involved in the defective Ig L chain expres-
sion ofthe analyzed tumors. Only 4 of22 Ig Hchain-negative tumors had L chain
expression. It is very unlikely that similar translocations and deletions are involved
in both the L chain andthe H chain genes in single tumors. More likely, regulatory
events may play a role (18, 19).
In conclusion, various moleculardefects on the gene level may account fordefects
in the Ig H chain synthesis in FCC-derived lymphomas. Our data show that the
among these defects t(14;18), translocation, which is essentially related to this type
of lymphoma, plays a major role.
Summary
Although follicle center cell (FCC) lymphomas represent mature B cells, a con-
siderable percentage do not have detectable Ig production. We have used Southernblotting and the polymerase chain reaction (PCR) to study the involvement of trans-
let,atlon§ ¬(14;18) and t(8;14) in causing defective Ig production in 16 Ig- FCC-
derived lymphomas and three Ig- B cell acute lymphoblastic leukemias. In 6 of 19
cases, a t(14;18) was present with the other allele either deleted or in germline. In
two cases a t(14;18) and a t(8;14) affected both Ig alleles, as confirmed by karyotyping.
In two other cases, rearrangement of both bcl-2 on chromosome 18 and c-myc on
chromosome 8 were found as well. Although cytogenetic proof was not available,
the latter was probably involved in t(8;14). Restriction map analysis of one more
case showed rearrangement on the pseudoJH3 gene on one allele and t(14;18) on
the other. Thus, in 11 of 19 cases, defective Ig H chain production could be explained
by the inactivation of both Ig H chain genes due to translocation of one allele, in
combination with deletions or defective rearrangements of the other allele. In con-
trast, in 28 of 30 Ig+ lymphomas, one functional Ig H chain allele was found, ei-
ther in, or not in, combination with t(14;18). In two cases a single rearranged Ig H
chain allele was found in combination with rearrrangement ofbcl-2. No combgration
of the single Ig rearrangement with bcl-2, however, was found both by Southern
blotting and PCR, suggesting a variant bcl-2 translocation, which leaves the Ig H
chain allele functionally intact.
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